Showing results (331-340 of 407) with videos related to
Sort By:
Pageof 41
Parkinsonism & Related Disorders|December 2, 2014
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Anat Mirelman, et al.BMC Neurology|April 18, 2023
The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocolNoa Bregman, Tamara Shiner, Gitit Kavé, et al.Molecular Genetics and Metabolism|October 31, 2019
Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?Orly Goldstein, Mali Gana-Weisz, Danielle Cohen-Avinoam, et al.Frontiers in Neurology|June 6, 2019
Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's DiseaseTal Kozlovski, Alexis Mitelpunkt, Avner Thaler, et al.Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|January 30, 2013
Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriersAvner Thaler, Anat Mirelman, Rick C Helmich, et al.NPJ Parkinson'S Disease|March 4, 2022
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriersAmgad Droby, Moran Artzi, Hedva Lerman, et al.Stroke|February 14, 2015
Gait measures as predictors of poststroke cognitive function: evidence from the TABASCO studyEinor Ben Assayag, Shani Shenhar-Tsarfaty, Amos D Korczyn, et al.Stroke|February 28, 2013
Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volumeEfrat Kliper, Dafna Ben Bashat, Natan M Bornstein, et al.Neurology|June 12, 2015
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumKaren Marder, Yuanjia Wang, Roy N Alcalay, et al.Pageof 41